Nitrates are a class of medications primarily used in the management of cardiovascular conditions. They work by dilating blood vessels, which leads to improved blood flow and reduce workload on the heart. This class includes various compounds such as nitroglycerin, isosorbide dinitrate, and isosorbide mononitrate.
The discovery of nitrates dates back to ancient times, where natural deposits like sodium nitrate (saltpeter) and potassium nitrate were utilized. However, the scientific understanding of nitrates and their properties developed significantly over time.
In the 17th century, the Flemish chemist Jan Baptist van Helmont conducted experiments with various substances, including nitrates, laying some of the groundwork for understanding their chemical nature.
In the late 18th century, the Swedish chemist Carl Wilhelm Scheele and the British chemist Joseph Priestley independently discovered nitric oxide (NO), a key component in the formation of nitrates. This discovery paved the way for further research into nitrogen compounds.
In the early 19th century, the French chemist Antoine Lavoisier contributed to the understanding of nitrogen compounds by investigating their chemical properties and reactions. His work laid the foundation for the modern understanding of nitrates and other nitrogen-containing compounds.
Throughout the 19th and 20th centuries, further research led to the synthesis of various nitrates and their applications in agriculture, industry, and medicine. Today, nitrates continue to be essential compounds with diverse uses across different fields.
Nitrates are commonly used in clinical practice for the management of various cardiovascular conditions, including:
1. Angina pectoris: Nitrates such as nitroglycerin are effective in relieving angina symptoms by dilating coronary arteries, improving blood flow to the heart muscle, and reducing myocardial oxygen demand.
2. Acute myocardial infarction (heart attack): Nitrates can be administered to alleviate chest pain and improve coronary blood flow during an acute myocardial infarction.
3. Heart failure: Nitrates can be used in combination with other medications to manage heart failure symptoms by reducing preload and afterload, thereby improving cardiac output and relieving symptoms like dyspnea and edema.
4. Hypertension: Although not typically first-line agents, nitrates may be used to manage hypertension, especially in specific patient populations such as those with ischemic heart disease or heart failure.
5. Pulmonary hypertension: Nitrates can be beneficial in certain types of pulmonary hypertension by dilating pulmonary arteries and reducing pulmonary vascular resistance.
Additionally, nitrates may also be used in the treatment of acute decompensated heart failure, hypertensive emergencies, and perioperative management of cardiac surgery.
Nitroglycerin (NTG) – angina pectoris (treatment/prophylaxis), acute coronary syndrome, heart failure, hypertension
Isosorbide mononitrate (ISMN) – chronic angina pectoris (treatment)
Isosorbide dinitrate (ISDN) – angina pectoris (treatment/prophylaxis)
Isoket
Intravenous injection
Nitroard
ORAL
Dinitra
Oral
Deponit N5
Transdermal
The pharmacokinetics of nitrates involve absorption, distribution, metabolism, and excretion.
Nitrates are rapidly absorbed through various routes, including sublingual, oral, transdermal, and intravenous. They distribute quickly to tissues, especially those with high blood flow.
Metabolism primarily occurs in the liver, where nitrates are converted to nitric oxide (NO) or inactive metabolites.
Excretion is mainly through urine.
Nitroglycerin, for example, has a short half-life due to rapid metabolism, requiring frequent dosing for sustained effect.
Absorption
Nitrate drugs, like nitroglycerin, are often administered sublingually (under the tongue) for rapid absorption into the bloodstream.
The mucous membranes under the tongue have a rich blood supply, allowing for quick absorption and onset of action. When taken orally, nitrate drugs are typically absorbed through the gastrointestinal tract.
However, their absorption can be variable due to factors like food intake, gastric pH, and individual differences in metabolism.
Distribution
Once absorbed, nitrate drugs are distributed throughout the body via the bloodstream.
They act on smooth muscle cells, including those in blood vessels, leading to vasodilation.
This dilation can increase blood flow to various tissues and organs.
Nitrate drugs can also redistribute blood flow, potentially alleviating symptoms of conditions like angina by increasing blood flow to the heart muscle.
Metabolism
Nitrate drugs undergo metabolism primarily in the liver. One of the key metabolic pathways involves the conversion of organic nitrates, such as nitroglycerin, into nitric oxide (NO) through enzymatic processes.
Nitric oxide is a potent vasodilator and plays a crucial role in the mechanism of action of nitrate drugs.
Additionally, other metabolic pathways may involve the conversion of nitrates into inactive metabolites, which are then excreted from the body.
Excretion
Nitrate drugs and their metabolites are primarily excreted from the body through the urine.
After metabolism in the liver and systemic circulation, the resulting metabolites, including nitric oxide (NO) and inactive breakdown products, are filtered by the kidneys and eliminated via urine. Some small amounts may also be excreted in the feces and exhaled as gases.
Organic nitrates serve as potential nitric oxide (NO) donors within biological systems.
Their effects are not observed in cell-free environments; instead, they function as pro-drugs requiring bioactivation via enzymatic or non-enzymatic pathways to release NO.
High-potency nitrates, such as glyceryl trinitrate (GTN) and pentaerythritol tetranitrate (PETN), undergo enzymatic bioactivation mediated by cytosolic and/or mitochondrial aldehyde dehydrogenase (ALDH2).
This process converts them into nitrite and denitrated metabolites.
In contrast, low-potency nitrates like isosorbide mononitrate (ISMN) and isosorbide dinitrate (ISDN) activate independently of ALDH2, typically occurring via endoplasmic reticulum-associated P450 enzymes.
Main adverse effects from nitrate use come from dilation of the venous blood vessels. Other side effects can be reflexes from the activation of the sympathetic nervous system or re-exposure after withdrawal.
These side effects include:
Monday disease (tachycardia, headache, and dizziness during re-exposure
DRUG-DRUG
Phosphodiesterase-5 (PDE-5) Inhibitors
PDE-5 inhibitors like sildenafil, tadalafil, and vardenafil can enhance nitrates' blood pressure-lowering effects.
Combining nitrates with PDE-5 inhibitors can cause dizziness, lightheadedness, and potential complications.
2.Alpha-Blockers
Drugs like doxazosin, terazosin, and prazosin can interact with nitrates, potentially leading to severe hypotension.
3.Beta-Blockers
Beta-blockers like Propranolol , and Metoprolol can reduce heart rate and contraction strength, potentially masking low blood pressure symptoms or reducing nitrates' effectiveness.
4.Calcium Channel Blockers
Certain calcium channel blockers like diltiazem and verapamil can interact with nitrates, increasing risk of side cardiac effects.
Several contraindications exist for the use of nitrate. They are the following:
Allergy to nitrates
Concomitant use of phosphodiesterase (PDE) inhibitors such as tadalafil and sildenafil
Right ventricular infarction
Hypertrophic cardiomyopathy